We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.25B
AUM Growth
+$136M
Cap. Flow
+$60.6M
Cap. Flow %
4.87%
Top 10 Hldgs %
22.84%
Holding
2,021
New
430
Increased
368
Reduced
444
Closed
703

Sector Composition

Rank Sector Weight
1 Technology 16.16%
2 Communication Services 12.62%
3 Healthcare 9.79%
4 Consumer Discretionary 7.25%
5 Industrials 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDXS icon
451
Codexis
CDXS
$158M
$408K 0.03%
+48,891
New +$338K
MCO icon
452
Moody's
MCO
$83.8B
$408K 0.03%
+2,762
New +$405K
XLU icon
453
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$407K 0.03%
+15,466
New +$424K
EXAC
454
DELISTED
Exactech Inc
EXAC
$405K 0.03%
8,195
+5,395
+193% +$228K
AON icon
455
CALL
Aon
AON
$75B
$402K 0.03%
+3,000
New +$427K
MO icon
456
Altria Group
MO
$113B
$401K 0.03%
5,617
+525
+10% +$35.2K
DENN
457
DELISTED
Denny's
DENN
$399K 0.03%
30,137
+2,589
+9% +$33.7K
MA icon
458
Mastercard
MA
$501B
$397K 0.03%
2,625
+1,361
+108% +$202K
CSIQ icon
459
Canadian Solar
CSIQ
$1.08B
$396K 0.03%
23,500
-4,243
-15% -$72.9K
GWPH
460
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$395K 0.03%
+2,992
New +$352K
ADAP
461
DELISTED
Adaptimmune Therapeutics
ADAP
$393K 0.03%
58,853
+14,294
+32% +$110K
RSG icon
462
Republic Services
RSG
$64.1B
$393K 0.03%
5,815
-396
-6% -$25.5K
ALSN icon
463
Allison Transmission
ALSN
$10.2B
$392K 0.03%
9,100
-12,900
-59% -$526K
CELG
464
DELISTED
Celgene Corp
CELG
$392K 0.03%
3,755
-15,946
-81% -$1.8M
RRGB icon
465
Red Robin
RRGB
$150M
$391K 0.03%
6,937
-708
-9% -$40.7K
SRE icon
466
Sempra
SRE
$57B
$391K 0.03%
+7,316
New +$424K
GNCMA
467
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$390K 0.03%
10,000
+3,400
+52% +$139K
MSFG
468
DELISTED
MainSource Financial Group Inc
MSFG
$381K 0.03%
10,489
+5,289
+102% +$198K
NUAN
469
DELISTED
Nuance Communications, Inc.
NUAN
$379K 0.03%
26,808
+21,379
+394% +$288K
POT
470
DELISTED
Potash Corp Of Saskatchewan
POT
$379K 0.03%
18,375
+4,225
+30% +$81.9K
CYTK icon
471
Cytokinetics
CYTK
$10.8B
$378K 0.03%
46,338
+10,534
+29% +$120K
PRTK
472
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$377K 0.03%
21,048
+442
+2% +$9.22K
VOD icon
473
Vodafone
VOD
$36.2B
$376K 0.03%
+11,780
New +$353K
SPIL
474
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
$375K 0.03%
+44,647
New +$360K
EXPE icon
475
Expedia Group
EXPE
$37B
$373K 0.03%
+3,111
New +$404K

Similar funds

Prelude Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Prelude Capital Management held 2,021 positions worth $1.25B, up 12% from $1.11B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Prelude Capital Management deployed $60.6M of net new capital in Q4 2017, opening 430 new positions and adding to 368 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 328,795 shares worth $11.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Western Digital, an estimated $7.02M trimmed.

  • Prelude Capital Management's largest Q4 2017 buy was Twenty-First Century Fox, Inc. Class B: 328,795 shares worth $11.2M.
  • Prelude Capital Management added most to NXP Semiconductors in Q4 2017, an estimated $28M increase.
  • Prelude Capital Management's biggest Q4 2017 reduction was Western Digital, cutting an estimated $7.02M.
  • Prelude Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $30M.
  • Prelude Capital Management's ten largest holdings make up 23% of its $1.25B portfolio in Q4 2017.
  • Prelude Capital Management opened 430 new positions and closed 703 in Q4 2017.
  • Prelude Capital Management's portfolio value rose 12% quarter-over-quarter to $1.25B.

Based on Prelude Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.